Jul 01, 2015 (ACCESSWIRE via COMTEX) -- Adds Industrial Chemistry and Product Development to Core Consulting Services; Improves Position for Opportunities in Essential Oils

CHATSWORTH, CA / ACCESSWIRE / July 1, 2015 / VAPE Holdings, Inc. (otcqb:VAPE) (the "Company" or "VAPE"), a holding company focused on providing healthy, efficient, and sustainable products to lawfully operating participants in the legal cannabis industry, is pleased to announce that it has acquired control and 80% of the equity of Pennsylvania-based BetterChem Consulting, Inc. ("BetterChem") in exchange for restricted common stock, and for other share-based consideration based on performance over the next two years.

By David Murét

There are a couple things we know for certain about operating a company on the front lines of legal cannabis: It isn’t easy, and it isn’t cheap.

As an entrepreneur or executive in this industry, the demands on your finite resources seem endless. When you consider the risks of being under-capitalized in such a volatile market, it seems wise to trim costs wherever you can. For many companies that means turning to one of the countless job boards to search for talent. Why engage the services of a recruiter when a single job posting on Craigslist can yield hundreds of resumes?

Controlling mold spores, powdery mildew, fungus, bacteria and other maladies from infiltrating cultivation and processing facilities is a significant challenge for those in the cannabis industry.

Using technology developed by NASA, KesAir has introduced a product designed for safe, energy-efficient, chemical-free and effective air sanitation for any type of environment.

AiroCide uses a photocatalytic reactor (rather than a filter) to kill airborne bacteria, mold/fungus, viruses, allergens and mycotoxins.

It produces no ozone, while oxidizing volatile organic compounds (VOCs), to remove harmful gases and undesirable odors.

The global biosimilars market value is expected to reach $20 billion by the end of 2015 and could hit $55 billion by 2020, with growth primarily driven by a promising pipeline in active development and government efforts to reduce healthcare spending, according to business intelligence provider GBI Research.

The company’s latest CBR Pharma report states that biologics currently account for between 17–20 percent of the pharmaceutical arena, with a value of nearly $200 billion, and these products may replace 70 percent of chemical drugs in the next two decades.

The 30 percent to 50 percent reduction in biosimilar prices compared with branded biologics could lead to considerable savings in healthcare expenditure.

Corruption undermining science.

In a perfect world, science would have unlimited funding, free from corporations or special interest groups, where all studies would be truly objective and unbiased. Unfortunately, this is rarely the case. Financing by private companies, or those who have a vested interest in the outcome of the research, often leads to biased conclusions which favor the sponsor of the study.

TEMPE, AZ--(Marketwired - Jun 29, 2015) - American Green, Inc. (OTC PINK: ERBB) is very pleased to announce today that it has executed an acquisition agreement with TrackX, LLC(www.TrackX.com). TrackX, a Denver-based company, is one of the country's leading providers of complete Radio Frequency Identification (RFID) tracking and cloud-based physical asset management systems. TrackX owns and maintains process patents and services designed to cater to numerous nationally recognized customers. American Green believes that TrackX is positioned to be the premiere RFID-enabled asset tracking and supply chain solutions provider globally.

PharmaCyte Story to Reach More Than 96 Million U.S. Households on June 30

Jayne Pimentel is high on marijuana marketing – in particular using ad tech to support a budding industry.

Pimentel, currently Reddit’s ad ops chief and formerly demand-side platform Turn’s director of emerging media, is also founder of CanX – an app designed to connect cannabis growers, product producers, dispensaries and consumers.

It uses anonymous registration data that lets producers see which products from which dispensaries are most popular. Consequently, they can market on a one-to-one basis to people on CanX.

“CanX is similar to programmatic, in that you can use data on the supply side,” Pimentel explained. “If you think of the producers as the supply side and the consumer as the demand, we’re trying to connect those pipes.”

YAKIMA, Wash. -- There are less than a dozen marijuana testing labs in the entire state. One lab opened in Yakima a year ago and today, they're still working on developing technology which could lead to some major scientific discoveries. Scientists are testing THC, the psychoactive chemical in marijuana, and other chemical compounds.

Research advancements have made it more profitable for growers and retailers. New this year, a process which determines the sex of marijuana plants, soon after seeds have sprouted. 

"It frees up more space for more of the female plants, the desirable plants," said Analytical 360 Scientist, Max Rutter.

Marijuana home grows can get messy and complicated. First you need to devote a room or closet to the endeavor, or rig up a tent or large cabinet where you can carefully control heating and light (to say nothing of prying eyes). Then you have to monitor and tweak water levels, light cycles, plant nutrients and the pH balances of your grow medium, plus watch out for pests. All this has to be repeated for several months until your plants’ buds are ready to be harvested, dried and cured. It’s like taking biology class, mastering a home-chemistry lab and going for a Boy Scouts’ merit badge at the same time -- and, usually, the whole operation is concealed from those prying eyes. Growing marijuana at home has long been hidden away.